Healthcare Services Group, Inc. (HCSG) — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. Although the request references 2022 Q4, this is an annual filing; the supplied text does not provide standalone fourth-quarter results.
Business context
HCSG provides housekeeping, laundry, linen, facility maintenance and dietary management services to U.S. healthcare facilities. It served approximately 2,600 facilities in Housekeeping and 1,700 in Dietary. The company reported two operating segments and employed approximately 35,700 people at year-end.
Financial performance and liquidity
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Revenue | $1,690.2 million | $1,642.0 million | +2.9% |
| Income before taxes | $45.1 million | $61.8 million | -27.1% |
| Net income | $34.6 million | $45.9 million | -24.5% |
| Diluted EPS | $0.47 | $0.61 | Down $0.14 |
| Cash from operations | $(8.2) million | $37.1 million | Declined $45.3 million |
- Costs of services were $1,496.3 million, or 88.5% of revenue, versus 86.2% in 2021. Net margin was approximately 2.0%, compared with 2.8%.
- Housekeeping revenue fell 3.1% to $795.7 million; Dietary revenue rose 9.0% to $894.5 million. Segment income before taxes was $73.1 million for Housekeeping and $29.1 million for Dietary, compared with $79.4 million and $45.8 million, respectively, in 2021.
- Year-end cash and cash equivalents plus marketable securities totaled $121.5 million, down from $185.2 million. Working capital was $330.0 million, and the current ratio was 2.8:1.
- Net accounts and notes receivable were $369.4 million, up from $322.6 million; the allowance for doubtful accounts was approximately $73.5 million. Operating cash flow was pressured by a $78.7 million increase in receivables and payment of $24.4 million in previously deferred payroll taxes.
- HCSG had $25.0 million drawn on its $300 million revolving credit facility and $81.0 million of standby letters of credit, leaving $194.0 million available at year-end. It reported compliance with its covenants. The facility expires November 22, 2027.
- Capital expenditures were $5.2 million. Management estimated 2023 capital expenditures of $4.0–$6.0 million and stated that available liquidity and credit capacity should fund operations for the next twelve months.
Material changes and unusual items
- Bad debt provision increased to $32.0 million from $10.5 million. The filing cites aging receivables and a customer operating group entering receivership; that receivership increased provision by approximately $7.1 million.
- A contract modification reduced 2022 revenue by $10.0 million. The filing attributes $2.3 million of the reduction to Housekeeping and $7.7 million to Dietary.
- Self-insurance costs benefited from a favorable $9.8 million adjustment to reserves for prior claims, based on updated actuarial estimates and favorable claims experience.
- Consolidated SG&A fell 18.9% to $140.3 million, partly due to lower legal and professional fees following resolution of a previously disclosed SEC matter. Deferred compensation investment losses reduced reported SG&A, while investment and other income shifted from $9.4 million of income to $5.4 million of expense.
- Genesis Healthcare accounted for 10.0% of revenue, down from 10.8% in 2021. At year-end, HCSG had $36.2 million of accounts receivable and $20.4 million of notes receivable from Genesis; the parties continued discussions regarding a longer-term contract structure.
Outlook, risks and contingencies
HCSG did not provide specific revenue or earnings guidance in the supplied filing text. Management described growth priorities as winning new customers, expanding services to existing customers, obtaining modest price increases and controlling costs. It also cited continuing labor shortages, wage growth, inflation, supply-chain disruption and nursing-home occupancy below pre-pandemic levels. The company seeks to pass cost increases to customers, but timing or contractual limits may delay or prevent full recovery.
- Customer credit and collections are material risks: many customers depend on Medicare and Medicaid reimbursement, and weaker customer finances may raise bad debts or delay payments.
- Customer concentration remains significant. Genesis is the only customer disclosed as exceeding 10% of revenue; loss of the relationship or failure to meet payment terms could materially affect results and cash flows.
- Service agreements are generally renewable one-year contracts and may be cancelled on 30–90 days’ notice after an initial period.
- HCSG relies on Sysco to distribute more than half of its food and non-food dining supplies. Disruption could affect operations and costs.
- Self-insured workers’ compensation and general-liability reserves rely on actuarial estimates. COVID-19-related claims, medical cost inflation or unfavorable claim development could increase liabilities.
- The company disclosed pending ordinary-course legal and administrative matters, including employment-related matters. For certain claims, it could not reasonably estimate losses or determine the likelihood of an unfavorable outcome. Tax matters were also disclosed, with no reasonable liability estimate; management did not expect them to have a material adverse effect based on its best estimate.
- On February 14, 2023, the Board authorized repurchases of up to 7.5 million shares and suspended the quarterly dividend as part of a capital-rebalancing strategy. HCSG had paid $63.4 million of dividends during 2022.
- The auditor issued unqualified opinions on the financial statements and internal control over financial reporting. The allowance for doubtful accounts was identified as a critical audit matter because of estimation uncertainty and management judgment.
Key facts for investors to verify
- Whether receivable growth and the elevated bad-debt provision stabilize, particularly for aged balances, receivership-related exposures and Genesis.
- Whether revenue growth converts to improved margins as labor, food and other supply costs evolve, especially in Dietary.
- Whether operating cash flow recovers after the 2022 working-capital outflow and payroll-tax payment.
- The ongoing status and terms of the Genesis relationship, including collections and any long-term contract arrangement.
- The financial effects of the dividend suspension and share-repurchase authorization, and actual repurchase activity after year-end.
- Developments in litigation, tax matters and actuarial insurance reserves, for which outcomes or potential losses were not fully quantifiable in the filing.